Surgical resection remains the standard treatment for early-stage non–small cell lung cancer (NSCLC) management.
1 Patients with NSCLC should receive timely treatment given that delayed surgical treatment holds a theoretical risk for disease progression and therefore poor prognosis.
2,3 While several studies
4-7 found that delayed surgical treatment is associated with worse outcomes, other studies
8-10 found no association. Therefore, whether there is a safe period of time between lung cancer diagnosis and surgical treatment, or treatment in general, remains unclear.